Morgan Stanley Psychemedics Corp Transaction History

Morgan Stanley

$1.27 Trillion
Q2 2024

A detailed history of Morgan Stanley transactions in Psychemedics Corp stock. As of the latest transaction made, Morgan Stanley holds 3,001 shares of PMD stock, worth $6,992. This represents 0.0% of its overall portfolio holdings.

Number of Shares

3,001

Previous 3,501 14.28%

Holding current value

$6,992

Previous $10,000 30.0%

% of portfolio

0.0%

Previous 0.0%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$2.25 - $2.88 $1,125 - $1,440	-500 Reduced 14.28%	3,001 $7,000
Q4 2023 Aug 16, 2024	BUY	$2.06 - $3.69 $1,030 - $1,845	500 Added 16.66%	3,501 $10,000
Q4 2023 Feb 13, 2024	SELL	$2.06 - $3.69 $2,057 - $3,686	-999 Reduced 22.2%	3,501 $10,000
Q3 2023 Nov 15, 2023	SELL	$3.66 - $5.05 $44,073 - $60,812	-12,042 Reduced 72.8%	4,500 $17,000
Q2 2023 Aug 14, 2023	BUY	$4.55 - $5.6 $1,237 - $1,523	272 Added 1.67%	16,542 $75,000
Q1 2023 May 15, 2023	BUY	$4.93 - $6.47 $21,761 - $28,558	4,414 Added 37.23%	16,270 $85,000
Q4 2022 Feb 14, 2023	SELL	$4.9 - $6.7 $38,592 - $52,769	-7,876 Reduced 39.91%	11,856 $58,000
Q3 2022 Nov 14, 2022	BUY	$6.08 - $6.84 $3,496 - $3,933	575 Added 3.0%	19,732 $127,000
Q2 2022 Oct 27, 2022	BUY	$6.1 - $7.04 $86,260 - $99,552	14,141 Added 281.92%	19,157 $122,000
Q2 2022 Aug 15, 2022	BUY	$6.1 - $7.04 $86,260 - $99,552	14,141 Added 281.92%	19,157 $122,000
Q1 2022 Oct 27, 2022	SELL	$6.49 - $7.56 $91,775 - $106,905	-14,141 Reduced 73.82%	5,016 $35,000
Q1 2022 May 13, 2022	BUY	$6.49 - $7.56 $25 - $30	4 Added 0.08%	5,016 $35,000
Q4 2021 Feb 14, 2022	SELL	$6.86 - $8.79 $7,998 - $10,249	-1,166 Reduced 18.87%	5,012 $35,000
Q3 2021 Nov 15, 2021	BUY	$6.31 - $8.4 $38,983 - $51,895	6,178 New	6,178 $52,000

Others Institutions Holding PMD

# of Institutions

Shares Held

1.19M

Call Options Held

Put Options Held

View Full List

About PSYCHEMEDICS CORP

Ticker PMD
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 5,626,200
Market Cap $13.1M
Description
Psychemedics Corporation provides testing services for the detection of drugs of abuse through the analysis of hair samples in the United States, Brazil, and internationally. The company offers screening and confirmation by mass spectrometry using industry-accepted practices for cocaine, marijuana, and PCP; amphetamines, including ecstasy, eve, ...

More about PMD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Morgan Stanley, based on Form 13F filings with the SEC.

News

Stay updated on Morgan Stanley with notifications on news.

Account